颈动脉支架术中同期处理共干病变增加卒中和死亡风险
基于2005至2020年血管研究组新英格兰数据,对比颈动脉支架术治疗串联病变与孤立病变的预后。串联病变组30天死亡率2.2% vs 0.6%,围术期神经事件8.1% vs 2.0%,卒中或死亡5.9% vs 1.9%,多变量分析示串联病变为预测因素(OR 3.10)。
要点
- 颈动脉支架术同期处理共干病变与围术期卒中或死亡风险增加三倍相关。
- 串联病变组30天死亡率、围术期神经事件及卒中或死亡发生率均显著高于孤立病变组。
- 多变量预测因素包括串联病变治疗、症状性病变、COPD、全身麻醉及年龄增长。
核心结论
- 颈动脉支架术同期血管内治疗串联共干病变与围术期卒中或死亡增加三倍相关,应尽可能避免。
研究设计与样本
- 回顾性队列研究,查询2005至2020年血管研究组新英格兰数据,纳入1950例患者共2016条颈动脉支架术。
- 排除急诊、双侧、非动脉粥样硬化指征、既往同侧CAS、ICA狭窄<50%及经颈动脉手术。
主要发现
- 串联病变组30天死亡率2.2% vs 孤立病变组0.6%(P = .039)。
- 串联病变组围术期神经事件(卒中或TIA)8.1% vs 2.0%(P < .001)。
- 串联病变组卒中或死亡发生率5.9% vs 1.9%(P = .002)。
- 多变量模型中串联病变治疗OR 3.10(95%CI 1.39-6.89;P = .006)。
- 其他预测因素:症状性病变OR 2.24(95%CI 1.21-4.17;P = .010),COPD OR 2.14(95%CI 1.17-3.92;P = .014),全身麻醉OR 3.34(95%CI 1.35-8.26;P = .009),年龄每增1岁OR 1.05(95%CI 1.01-1.09;P = .006)。
关键数值与推荐
- 串联病变组中女性占50.4% vs 33.0%(P < .001)。
- 串联病变组既往CEA史45.9% vs 35.4%(P = .014)。
- 串联病变组需多枚支架治疗ICA病变9.6% vs 5.2%(P = .027)。
- 症状性病变占42.3%(孤立42.2% vs 串联43.0%;P = .86)。
- ICA神经保护结局两组相似(串联成功94.1%失败3.7%;孤立成功96.3%失败1.8%;P = .29)。
临床怎么用
- 颈动脉支架术应尽可能避免同期处理串联共干病变,以降低围术期卒中或死亡风险。
- 对合并串联病变、症状性病变、COPD、全身麻醉及高龄患者应加强风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tandem carotid artery lesions that involve simultaneous internal carotid artery (ICA) and common carotid artery (CCA) stenoses present a complex clinical problem. Some studies have shown that the addition of a retrograde proximal intervention to treat a CCA lesion during a carotid endarterectomy (CEA) increases the risk of stroke and death. However, the stroke and death risks associated with a totally endovascular approach to tandem lesions is unknown and is the subject of this study. METHODS: Vascular Study Group of New England data for the years 2005 to 2020 were queried for carotid artery stenting (CAS) procedures. Emergent and bilateral procedures, procedures for indications other than atherosclerosis, patients with prior ipsilateral CAS, ICA lesions with stenosis of less than 50%, and transcarotid procedures were excluded. The cohort was divided into tandem and isolated lesion groups. The primary outcome was the composite of stroke and death. Predictors of stroke or death were determined with multivariable logistic regression. RESULTS: There were 2016 carotid arteries stented in 1950 patients-1881 (96%) with isolated lesions and 135 (4%) with tandem lesions. The mean patient age was 69.6 ± 9.0 years. Tandem lesions were more likely to be present in women (50.4% vs 33.0%; P < .001) and in patients with a prior carotid endarterectomy (45.9% vs 35.4%; P = .014). Other covariates were similar between the groups. Symptomatic lesions accounted for 42.3% of cases (isolated, 42.2% vs tandem, 43.0%; P = .86). Arteries in the tandem group more often required multiple stents to treat the ICA lesion (9.6% vs 5.2%; P = .027). ICA neuroprotection had similar outcomes in both groups (tandem: success 94.1%, failure 3.7%; isolated: success 96.3%, failure 1.8%; P = .29). The tandem group experienced a higher 30-day mortality (2.2% vs 0.6%; P = .039), more perioperative neurologic events (stroke or transient ischemic attack) (8.1% vs 2.0%; P < .001), and a higher incidence of stroke or death (5.9% vs 1.9%; P = .002). Predictors of the primary outcome in the multivariable model included treatment of tandem lesions (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.39-6.89; P = .006), symptomatic lesions (OR, 2.24; 95% CI, 1.21-4.17; P = .010), chronic obstructive pulmonary disease (OR, 2.14; 95% CI, 1.17-3.92; P = .014), general anesthesia (OR, 3.34; 95% CI, 1.35-8.26; P = .009), and advancing age (OR, 1.05 per year; 95% CI, 1.01-1.09; P = .006). CONCLUSIONS: The addition of endovascular treatment of tandem CCA lesions with CAS is associated with a three-fold increase in perioperative stroke and death and should be avoided if possible.
引用
- DeCarlo C, Tanious A, Boitano LT, et al. Simultaneous treatment of common carotid lesions increases the risk of stroke and death after carotid artery stenting. J Vasc Surg. 2021. PMID: 33545307. doi:10.1016/j.jvs.2020.12.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。